Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Nuclear magnetic resonance investigation of water transport through the plasma membrane of various yeast species.

Šoltésová M, Elicharová H, Srb P, Růžička M, Janisova L, Sychrová H, Lang J.

FEMS Microbiol Lett. 2019 Sep 1;366(18). pii: fnz220. doi: 10.1093/femsle/fnz220.

PMID:
31778539
2.

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade.

Ruzicka M, Koenig LM, Formisano S, Boehmer DFR, Vick B, Heuer EM, Meinl H, Kocheise L, Zeitlhöfler M, Ahlfeld J, Kobold S, Endres S, Subklewe M, Duewell P, Schnurr M, Jeremias I, Lichtenegger FS, Rothenfusser S.

Leukemia. 2019 Nov 18. doi: 10.1038/s41375-019-0639-x. [Epub ahead of print]

PMID:
31740809
3.

Effect of hemodialysis on extracellular vesicles and circulating submicron particles.

Ruzicka M, Xiao F, Abujrad H, Al-Rewashdy Y, Tang VA, Langlois MA, Sorisky A, Ooi TC, Burger D.

BMC Nephrol. 2019 Aug 2;20(1):294. doi: 10.1186/s12882-019-1459-y.

4.

Alpha-Blocker Use and the Risk of Hypotension and Hypotension-Related Clinical Events in Women of Advanced Age.

Hiremath S, Ruzicka M, Petrcich W, McCallum MK, Hundemer GL, Tanuseputro P, Manuel D, Burns K, Edwards C, Bugeja A, Magner P, McCormick B, Garg AX, Rhodes E, Sood MM.

Hypertension. 2019 Sep;74(3):645-651. doi: 10.1161/HYPERTENSIONAHA.119.13289. Epub 2019 Jul 22.

PMID:
31327266
5.

Bending of DNA duplexes with mutation motifs.

Růžička M, Souček P, Kulhánek P, Radová L, Fajkusová L, Réblová K.

DNA Res. 2019 Aug 1;26(4):341-352. doi: 10.1093/dnares/dsz013.

6.

Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant Hypertension.

Ruzicka M, Leenen FHH, Ramsay T, Bugeja A, Edwards C, McCormick B, Hiremath S.

JAMA Intern Med. 2019 Jun 17. doi: 10.1001/jamainternmed.2019.1455. [Epub ahead of print] No abstract available.

PMID:
31206124
7.

Cause, Consequence or confounding? The kidney in hypertension.

Ruzicka M, Hiremath S.

J Hum Hypertens. 2019 Sep;33(9):639-640. doi: 10.1038/s41371-019-0199-6. Epub 2019 Apr 16. No abstract available.

PMID:
30992515
8.

Oscillations of pH in the urea-urease system in a membrane reactor.

Muzika F, RůŽička M, Schreiberová L, Schreiber I.

Phys Chem Chem Phys. 2019 Apr 24;21(17):8619-8622. doi: 10.1039/c9cp00630c.

PMID:
30985845
9.

On the mechanism of colloidal silica action to improve flow properties of pharmaceutical excipients.

Tran DT, Majerová D, Veselý M, Kulaviak L, Ruzicka MC, Zámostný P.

Int J Pharm. 2019 Feb 10;556:383-394. doi: 10.1016/j.ijpharm.2018.11.066. Epub 2018 Dec 6.

PMID:
30529657
10.

Behind the Mask.

Ruzicka M, Hiremath S.

Hypertension. 2018 Oct;72(4):841-842. doi: 10.1161/HYPERTENSIONAHA.118.11681. No abstract available.

PMID:
30354729
11.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
12.

Thiazide diuretic-caused hyponatremia in the elderly hypertensive: will a bottle of Nepro a day keep hyponatremia and the doctor away? Study protocol for a proof-of-concept feasibility trial.

Ruzicka M, McCormick B, Magner P, Ramsay T, Edwards C, Bugeja A, Hiremath S.

Pilot Feasibility Stud. 2018 Apr 6;4:71. doi: 10.1186/s40814-018-0263-y. eCollection 2018.

13.

Physicochemical approach to alkaline flocculation of Chlorella vulgaris induced by calcium phosphate precipitates.

Branyikova I, Filipenska M, Urbanova K, Ruzicka MC, Pivokonsky M, Branyik T.

Colloids Surf B Biointerfaces. 2018 Jun 1;166:54-60. doi: 10.1016/j.colsurfb.2018.03.007. Epub 2018 Mar 6.

PMID:
29544128
14.

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

Langote A, Hiremath S, Ruzicka M, McCormick BB.

PLoS One. 2017 Nov 10;12(11):e0187269. doi: 10.1371/journal.pone.0187269. eCollection 2017.

15.

Longitudinal Blood Pressure in Late-Stage Chronic Kidney Disease and the Risk of End-Stage Kidney Disease or Mortality (Best Blood Pressure in Chronic Kidney Disease Study).

Sood MM, Akbari A, Manuel DG, Ruzicka M, Hiremath S, Zimmerman D, McCormick B, Taljaard M.

Hypertension. 2017 Dec;70(6):1210-1218. doi: 10.1161/HYPERTENSIONAHA.117.09855. Epub 2017 Oct 23.

PMID:
29061722
16.

Thus Far and No Further: Should Diastolic Hypotension Limit Intensive Blood Pressure Lowering?

Ruzicka M, Edwards C, McCormick B, Hiremath S.

Curr Treat Options Cardiovasc Med. 2017 Sep 14;19(10):80. doi: 10.1007/s11936-017-0577-8. Review.

PMID:
28913677
17.

DNA mutation motifs in the genes associated with inherited diseases.

Růžička M, Kulhánek P, Radová L, Čechová A, Špačková N, Fajkusová L, Réblová K.

PLoS One. 2017 Aug 2;12(8):e0182377. doi: 10.1371/journal.pone.0182377. eCollection 2017.

18.

Microparticle Formation in Peritoneal Dialysis: A Proof of Concept Study.

Akbari S, Abou-Arkoub R, Sun S, Hiremath S, Reunov A, McCormick BB, Ruzicka M, Burger D.

Can J Kidney Health Dis. 2017 Mar 22;4:2054358117699829. doi: 10.1177/2054358117699829. eCollection 2017.

19.

Are Automated Blood Pressure Monitors Comparable to Ambulatory Blood Pressure Monitors? A Systematic Review and Meta-analysis.

Jegatheswaran J, Ruzicka M, Hiremath S, Edwards C.

Can J Cardiol. 2017 May;33(5):644-652. doi: 10.1016/j.cjca.2017.01.020. Epub 2017 Feb 1. Review.

PMID:
28449834
20.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NRC, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Kline G, Leiter LA, Jones C, Côté AM, Woo V, Kaczorowski J, Trudeau L, Tsuyuki RT, Hiremath S, Drouin D, Lavoie KL, Hamet P, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; Hypertension Canada.

Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10. Erratum in: Can J Cardiol. 2017 Dec;33(12 ):1733-1734.

PMID:
28449828
21.

Accuracy-Limiting Factor of Home Blood Pressure Monitors?

Ruzicka M, Hiremath S.

Am J Hypertens. 2017 Jul 1;30(7):661-664. doi: 10.1093/ajh/hpx056. No abstract available.

PMID:
28430845
22.

Balancing Overscreening and Underdiagnosis in Secondary Hypertension: The Case of Fibromuscular Dysplasia.

Ruzicka M, Kucharski SE, Hiremath S.

Cardiol Clin. 2017 May;35(2):247-254. doi: 10.1016/j.ccl.2016.12.006. Review.

PMID:
28411898
23.

Precision Medicine for Hypertension Management in Chronic Kidney Disease: Relevance of SPRINT for Therapeutic Targets in Nondiabetic Renal Disease.

Ruzicka M, Burns KD, Hiremath S.

Can J Cardiol. 2017 May;33(5):611-618. doi: 10.1016/j.cjca.2017.01.007. Epub 2017 Jan 20. Review.

PMID:
28365055
24.

Time-Varying Association of Individual BP Components with eGFR in Late-Stage CKD.

Sood MM, Akbari A, Manuel D, Ruzicka M, Hiremath S, Zimmerman D, McCormick B, Taljaard M.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):904-911. doi: 10.2215/CJN.05640516. Epub 2017 Mar 29.

25.

Intensive blood pressure lowering in chronic kidney disease: the time has come.

Ruzicka M, Hiremath S.

Curr Opin Nephrol Hypertens. 2017 May;26(3):197-204. doi: 10.1097/MNH.0000000000000316. Review.

PMID:
28198732
26.

Sensitive Versatile Fluorogenic Transmembrane Peptide Substrates for Rhomboid Intramembrane Proteases.

Tichá A, Stanchev S, Škerle J, Began J, Ingr M, Švehlová K, Polovinkin L, Růžička M, Bednárová L, Hadravová R, Poláchová E, Rampírová P, Březinová J, Kašička V, Majer P, Strisovsky K.

J Biol Chem. 2017 Feb 17;292(7):2703-2713. doi: 10.1074/jbc.M116.762849. Epub 2017 Jan 9.

27.

The association of urinary sodium excretion and the need for renal replacement therapy in advanced chronic kidney disease: a cohort study.

Mazarova A, Molnar AO, Akbari A, Sood MM, Hiremath S, Burns KD, Ramsay TO, Mallick R, Knoll GA, Ruzicka M.

BMC Nephrol. 2016 Sep 5;17(1):123. doi: 10.1186/s12882-016-0338-z.

28.

Interactions of helquats with chiral acidic aromatic analytes investigated by partial-filling affinity capillary electrophoresis.

Růžička M, Koval D, Vávra J, Reyes-Gutiérrez PE, Teplý F, Kašička V.

J Chromatogr A. 2016 Oct 7;1467:417-426. doi: 10.1016/j.chroma.2016.08.053. Epub 2016 Aug 26.

PMID:
27578406
29.

A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

McCormick BB, Hiremath S, Ruzicka M.

N Engl J Med. 2016 Jun 9;374(23):2291-2. doi: 10.1056/NEJMc1602668. No abstract available.

PMID:
27276573
30.

How Accurate Are Home Blood Pressure Devices in Use? A Cross-Sectional Study.

Ruzicka M, Akbari A, Bruketa E, Kayibanda JF, Baril C, Hiremath S.

PLoS One. 2016 Jun 1;11(6):e0155677. doi: 10.1371/journal.pone.0155677. eCollection 2016.

31.

Effect of colloidal silica on rheological properties of common pharmaceutical excipients.

Majerová D, Kulaviak L, Růžička M, Štěpánek F, Zámostný P.

Eur J Pharm Biopharm. 2016 Sep;106:2-8. doi: 10.1016/j.ejpb.2016.04.025. Epub 2016 May 7.

PMID:
27163240
32.

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; CHEP Guidelines Task Force.

Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.

PMID:
27118291
33.

Reproducibility of carotid-femoral pulse wave velocity in end-stage renal disease patients: methodological considerations.

Rodriguez RA, Cronin V, Ramsay T, Zimmerman D, Ruzicka M, Burns KD.

Can J Kidney Health Dis. 2016 Apr 1;3:20. doi: 10.1186/s40697-016-0109-6. eCollection 2016.

34.

Vascular Aging: Lessons From Pediatric Hypertension.

Litwin M, Feber J, Ruzicka M.

Can J Cardiol. 2016 May;32(5):642-9. doi: 10.1016/j.cjca.2016.02.064. Epub 2016 Feb 27. Review.

PMID:
27040097
35.

Diastolic Hypotension in a Tertiary Care Hypertension Clinic: Have We Gone Too Far?

Mace-Brickman T, Leduc W, Hiremath S, Ruzicka M, McCormick BB.

Can J Cardiol. 2016 May;32(5):695-700. doi: 10.1016/j.cjca.2015.08.026. Epub 2015 Sep 4.

PMID:
26806792
36.

Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension.

Ruzicka M, Hiremath S.

Curr Hypertens Rep. 2015 Sep;17(9):579. doi: 10.1007/s11906-015-0579-4. Review.

PMID:
26164465
37.

Does pragmatically structured outpatient dietary counselling reduce sodium intake in hypertensive patients? Study protocol for a randomized controlled trial.

Ruzicka M, Ramsay T, Bugeja A, Edwards C, Fodor G, Kirby A, Magner P, McCormick B, van der Hoef G, Wagner J, Hiremath S.

Trials. 2015 Jun 17;16:273. doi: 10.1186/s13063-015-0794-y.

38.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS.

Can J Cardiol. 2015 May;31(5):549-68. doi: 10.1016/j.cjca.2015.02.016. Review.

PMID:
25936483
39.

Lower blood pressure target in nondiabetic proteinuric chronic kidney disease is not justified.

McCormick BB, Hiremath S, Ruzicka M.

Kidney Int. 2014 Oct;86(4):855. doi: 10.1038/ki.2014.171. No abstract available.

40.

The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis.

Breau RH, Kokolo MB, Punjani N, Cagiannos I, Beck A, Niznick N, Buenaventura C, Cowan J, Knoll G, Momoli F, Morash C, Ruzicka M, Schachkina S, Tinmouth A, Xie HY, Fergusson DA.

Transfus Med Rev. 2014 Jul;28(3):145-55. doi: 10.1016/j.tmrv.2014.05.002. Epub 2014 May 18. Review.

PMID:
24958068
41.

Toward Evaluating the Usefulness of GlobalIllumination for Novices in Lighting Design Tasks.

Karlík O, Ruzicka M, Gassenbauer V, Pellacini F, Krivánek J.

IEEE Trans Vis Comput Graph. 2014 Jun;20(6):944-54. doi: 10.1109/TVCG.2013.248.

PMID:
26357310
42.

Short daily versus conventional hemodialysis for hypertensive patients: a randomized cross-over study.

Zimmerman DL, Ruzicka M, Hebert P, Fergusson D, Touyz RM, Burns KD.

PLoS One. 2014 May 29;9(5):e97135. doi: 10.1371/journal.pone.0097135. eCollection 2014.

43.

Study of deoxyribonucleic acid-ligand interactions by partial filling affinity capillary electrophoresis.

Růžička M, Čížková M, Jirásek M, Teplý F, Koval D, Kašička V.

J Chromatogr A. 2014 Jul 4;1349:116-21. doi: 10.1016/j.chroma.2014.04.061. Epub 2014 May 5.

PMID:
24861783
44.

Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.

Hiremath S, Froeschl M, Ruzicka M.

Curr Opin Cardiol. 2014 Jul;29(4):336-43. doi: 10.1097/HCO.0000000000000076. Review.

PMID:
24859619
45.

Reply to Dr Myers' commentary on the use of automated blood pressure machines in office blood pressure measurements.

Hiremath S, Edwards C, McCormick BB, Ruzicka M.

J Clin Hypertens (Greenwich). 2014 Jul;16(7):540. doi: 10.1111/jch.12332. Epub 2014 May 7. No abstract available.

46.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program.

Can J Cardiol. 2014 May;30(5):485-501. doi: 10.1016/j.cjca.2014.02.002. Epub 2014 Feb 22. Review.

47.

Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.

Ruzicka M, Quinn RR, McFarlane P, Hemmelgarn B, Ramesh Prasad GV, Feber J, Nesrallah G, MacKinnon M, Tangri N, McCormick B, Tobe S, Blydt-Hansen TD, Hiremath S.

Am J Kidney Dis. 2014 Jun;63(6):869-87. doi: 10.1053/j.ajkd.2014.03.003. Epub 2014 Apr 12.

PMID:
24725980
48.

What is the feasibility of implementing effective sodium reduction strategies to treat hypertension in primary care settings? A systematic review.

Ruzicka M, Hiremath S, Steiner S, Helis E, Szczotka A, Baker P, Fodor G.

J Hypertens. 2014 Jul;32(7):1388-94; discussion 1394. doi: 10.1097/HJH.0000000000000182. Review.

PMID:
24694380
49.

Autonomic nervous system dysregulation in pediatric hypertension.

Feber J, Ruzicka M, Geier P, Litwin M.

Curr Hypertens Rep. 2014 May;16(5):426. doi: 10.1007/s11906-014-0426-z. Review.

PMID:
24633841
50.

Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels.

Abujrad H, Mayne J, Ruzicka M, Cousins M, Raymond A, Cheesman J, Taljaard M, Sorisky A, Burns K, Ooi TC.

Atherosclerosis. 2014 Mar;233(1):123-9. doi: 10.1016/j.atherosclerosis.2013.12.030. Epub 2014 Jan 8.

PMID:
24529132

Supplemental Content

Loading ...
Support Center